← Back to dashboard
ISRG Robotics & Physical AI Surgical robotics leader Open in compare 3D performance Excel model

Intuitive Surgical

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Live metrics are partially unavailable

1 of 21 live fields are unavailable right now. The chart, thesis sections, and source links still make the page usable.

20 live 1 unavailable
Price $402.09 Live
1D Change +2.12% 1 day
Market Cap $144.06B Live
Enterprise Value $136.96B Current
Trailing P/E 46.1 TTM
Forward P/E 33.3 Forward
PEG Ratio 1.87x Yahoo est.
Price / Sales 13.1 TTM
EV / Revenue 12.4 TTM
Revenue Growth 18.5% YoY latest qtr
Earnings Growth 26.5% YoY latest qtr
Gross Margin 66.7% TTM
Operating Margin 33.6% TTM
Net Margin 28.4% TTM
ROE 17.4% TTM
Free Cash Flow $2.62B TTM
FCF Margin 23.7% TTM
Debt / Equity Latest qtr
Current Ratio 4.96x Latest qtr
Dividend Yield 0.00% Annualized
Next Earnings Oct 20, 2026 Calendar

Metric timing

This page mixes live market data, trailing fundamentals, and latest reported statement data.

Live / market snapshot

Price, 1D change, market cap, and enterprise value are current market-based figures.

TTM / forward

Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.

Latest quarter / dividend cadence

Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.

Revenue $10.06B Dec 31, 2025

latest annual revenue

Revenue $2.89B Jun 30, 2026

latest quarterly revenue

Net Income $2.86B Dec 31, 2025

latest annual profit

Net Income $818.1M Jun 30, 2026

latest quarterly profit

Dividend / Share $0.00 No regular dividend

annualized per share

Last Dividend No dividend history

latest ex-dividend cash amount

Price chart

Data loads live when the page opens.

Latest headlines

Recent company headlines. Each link opens the original article in a new tab.

Motley Fool Sep 22, 2026
2 Beaten-Down Stocks to Buy Before They Bounce Back

The market may be underestimating these companies.

Simply Wall St. Sep 22, 2026
Why Intuitive Surgical (ISRG) Is Up 6.5% After New da Vinci SP Transvaginal Approval – And What's Next

Earlier this month, Intuitive Surgical received CE mark approval for using its da Vinci SP single-port robotic system in transvaginal gynecologic procedures, adding to its existing approvals for a range of endoscopic and natural-orifice surgeries across Europe. This world's-first indication for the SP platform deepens Intuitive’s position in minimally invasive, scarless surgery by broadening its clinically supported use in complex anatomical spaces. We’ll now examine how this expanded...

StockStory Sep 22, 2026
1 S&P 500 Stock with Exciting Potential and 2 We Ignore

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Motley Fool Sep 21, 2026
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth

Abbott leads in absolute revenue, but Intuitive Surgical's growth rate tells a different story over the past eight quarters.

StockStory Sep 21, 2026
Q2 Earnings Roundup: Intuitive Surgical (NASDAQ:ISRG) And The Rest Of The Surgical Equipment & Consumables - Specialty Segment

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Intuitive Surgical (NASDAQ:ISRG) and its peers.

Zacks Sep 21, 2026
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine

Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.

Why it could benefit going forward

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.

Business snapshot

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.